Combining radiation and hyperthermia for advanced cervical cancer treatment
Official title: Multimodal Therapy of Advanced Cervical Cancer With Radiotherapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia
Run by University of Erlangen-Nürnberg Medical School · NCT03249519 · Data updated 2026-11-12
This study tests if combining radiation therapy and heat treatment can improve outcomes for people with advanced cervical cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 999 (estimated) |
| Sponsor | University of Erlangen-Nürnberg Medical School Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Erlangen) |
| Status | Recruiting |
| Started | August 1, 2017 |
| Main results expected | December 31, 2094 |
| Study ends | December 31, 2099 |
| Registry record updated | August 15, 2017 |
| Trial ID | NCT03249519 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with histologically confirmed cervical cancer at FIGO stages IIB to IVA.
✕Probably not a fit
Patients with uncontrolled cardiac conditions or those who are pregnant or lactating may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of combining radiation therapy or chemoradiation with interstitial brachytherapy and hyperthermia in patients with advanced cervical cancer. The aim is to enhance the treatment outcomes by leveraging the radio- and chemosensitive effects of hyperthermia. Eligible participants include those with histologically confirmed cervical carcinoma at specific stages, and the study will assess the clinical outcomes of this combined approach. The interventions include radiation, brachytherapy, Cisplatin, and hyperthermia.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment outcomes for patients with advanced cervical cancer.
How similar studies have gone: Other studies have shown promising results with similar combinations of therapies, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Histological confirmed carcinoma of the Cervix * FIGO-Stage IIB-IVA; earlier stages when inoperable or according to patient's wish * clinical M0; except: involvement of para-aortic lymph nodes * Age ≥ 18 years * ECOG ≤ 2 * Informed consent of the patient Exclusion Criteria: * Pre-existing uncontrolled cardiac disease, signs of cardiac failure, or rhythm disturbances requiring therapy * Cardiac Pacemaker * Myocardial infarction within the past 12 months * Congestive heart failure * Complete bundle branch block * New York Heart Association (NYHA) class III or IV heart disease * Disease that would preclude chemoradiation or deep regional hyperthermia * Metal implants (length \> 2cm or dense clusters of marker clips in the pelvis) * Active or therapy-resistent bladder infections * Pre-existing or concommitant immunodeficiency Syndrome * Pregnant or lactating women * Patients not willing to use effective contraception during and up to 6 months after therapy
Where it's running
-
Universitätsklinikum Erlangen, Strahlenklinik
Erlangen, Germany Recruiting
Study contacts
- Study coordinator: Oliver Ott, MD
- Email: st-studiensekretariat@uk-erlangen.de
- Phone: ++49 9131 85
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cervical screening and care options for women living with HIV who test positive for high-risk HPV
This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.
-
Hydrogel spacer to protect the rectum during cervical cancer radiotherapy
This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.
-
How cinema sessions during chemotherapy might help cervical cancer patients
We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.